Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 51-100 of 1147 result(s).
CYDY CytoDyn Inc
06/12/2025 12:38:00 PM
"something in a few days"....if no
CYDY CytoDyn Inc
06/12/2025 11:11:49 AM
100% facts. & using 88% instead of
CYDY CytoDyn Inc
06/11/2025 1:06:38 PM
Cleaning up the optics to a partner (5)
CYDY CytoDyn Inc
06/10/2025 7:29:13 PM
US Patent Office could for sure Ai
CYDY CytoDyn Inc
06/10/2025 6:09:50 PM
Yes sir -- & ESMO was pooled from t (3)
CYDY CytoDyn Inc
06/10/2025 6:01:06 PM
The FDA's review process for BTD re (2)
CYDY CytoDyn Inc
06/10/2025 5:47:06 PM
NCT04313075: This is a single arm, (3)
CYDY CytoDyn Inc
06/10/2025 9:09:13 AM
Remember it was multiple countries
CYDY CytoDyn Inc
06/10/2025 8:54:20 AM
Being the data was not corrupted pe (1)
CYDY CytoDyn Inc
06/10/2025 8:51:26 AM
KC --- i looked @ that news trials, (2)
CYDY CytoDyn Inc
06/10/2025 8:09:24 AM
Agree --- prostate too comes 2 mind (1)
CYDY CytoDyn Inc
06/10/2025 8:07:32 AM
KC, ... 3 pooled trials, 90 patient (4)
CYDY CytoDyn Inc
06/10/2025 4:00:01 AM
Sorry ....dam links ---copy this if (3)
CYDY CytoDyn Inc
06/10/2025 1:55:54 AM
No BTD application in history has e (2)
CYDY CytoDyn Inc
06/10/2025 1:45:17 AM
March 2025 Update The Company conti (2)
CYDY CytoDyn Inc
06/10/2025 12:40:53 AM
If you put 9 of the 21 brain mets a (1)
CYDY CytoDyn Inc
06/10/2025 12:17:21 AM
Past BTD application -- WOW !! All (4)
CYDY CytoDyn Inc
06/08/2025 5:54:13 PM
The global chemotherapy market was (7)
CYDY CytoDyn Inc
06/08/2025 5:08:44 PM
*PARP helps repair DNA when it beco (4)
CYDY CytoDyn Inc
06/08/2025 2:56:12 PM
Think 5 "MOA Synergies". Far beyond (2)
CYDY CytoDyn Inc
06/08/2025 4:26:19 AM
Yep. & a non-toxic cancer-free to 5 (3)
CYDY CytoDyn Inc
06/07/2025 8:09:46 PM
Haha...knw it wasn't. Yes sir...tim (2)
CYDY CytoDyn Inc
06/07/2025 7:37:08 PM
6,8,9 months ago i agree on being a (4)
CYDY CytoDyn Inc
06/07/2025 6:30:19 PM
Should....not she
CYDY CytoDyn Inc
06/07/2025 6:21:36 PM
Mgt has done a horrible job in how (6)
CYDY CytoDyn Inc
06/07/2025 2:04:11 PM
Research and Development (R&D) Tax (3)
CYDY CytoDyn Inc
06/06/2025 12:12:59 AM
1. Potential Application of DPA to (2)
CYDY CytoDyn Inc
06/05/2025 7:20:30 PM
I don't know --- i mean taking in a (3)
CYDY CytoDyn Inc
06/05/2025 6:31:17 PM
FDA today -- included Accelerated A (6)
CYDY CytoDyn Inc
06/04/2025 9:31:25 PM
3 yrs ago -- ICI Agreement with maj (8)
CYDY CytoDyn Inc
06/04/2025 8:32:47 PM
Haha --- rgt, again x's how many ti (5)
CYDY CytoDyn Inc
06/04/2025 7:05:16 PM
Why do we have to wait until testin (2)
CYDY CytoDyn Inc
06/04/2025 6:35:34 PM
Govts/Insurance would save a stunni (3)
CYDY CytoDyn Inc
06/04/2025 5:37:41 PM
Don't forget the 2022 Right to Try (3)
CYDY CytoDyn Inc
06/04/2025 4:33:18 PM
It's estimated that at least 12 mil (2)
CYDY CytoDyn Inc
06/02/2025 11:10:26 PM
I now think like some said --- even (5)
CYDY CytoDyn Inc
06/02/2025 10:58:25 PM
Combine the CFO directives: When wa
CYDY CytoDyn Inc
06/02/2025 10:23:39 PM
Multiple loose-end trials. CFO bloc (5)
CYDY CytoDyn Inc
06/02/2025 8:54:40 PM
Forgot -- liking this part too...." (3)
CYDY CytoDyn Inc
06/02/2025 8:45:24 PM
Employment Agreement between CytoDy (6)
CYDY CytoDyn Inc
05/31/2025 12:11:01 PM
Quick look around & Dr. Tripathy is (10)
CYDY CytoDyn Inc
05/31/2025 10:58:23 AM
Another drug: Tripathy's research a (8)
CYDY CytoDyn Inc
05/31/2025 1:21:33 AM
Tripathy's work has contributed to (9)
CYDY CytoDyn Inc
05/31/2025 12:43:13 AM
Pfizer's $90b Lipitor Vs LL: The la (3)
CYDY CytoDyn Inc
05/31/2025 12:41:59 AM
This is not your typical drug/model (2)
CYDY CytoDyn Inc
05/30/2025 9:31:18 PM
Dec. letter: "Entering 2025, the Co (7)
CYDY CytoDyn Inc
05/30/2025 4:22:40 PM
Dr. Tripathy treated Mermaidgirly's (10)
CYDY CytoDyn Inc
05/30/2025 4:19:33 PM
Dr. Tripathy 2024 article: Fits als (2)
CYDY CytoDyn Inc
05/30/2025 3:48:37 PM
New SAB member ---- Did i not say w (4)
CYDY CytoDyn Inc
05/29/2025 7:43:43 PM
Cytodyn able to back date amend for
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Understanding Amaroq Minerals Ltd's Major Shareholding Notifications
  • Maximizing Website Performance with Google Analytics Tracking
  • Transforming Construction: Green Building Materials Surge
  • Patrick O'Shea Appointed Vice President for Research at UMD
  • Monster Energy Shines with 21 Medals at X Games 2025
  • Innovative Lung Organoid Research Revolutionizes Medicine
  • Eyemart Express Unites for Cancer Research in Annual Event
  • Morton Salt Enhances Production Capabilities for Growth
  • Navigating Economic Trends: A Comprehensive Macro Review
  • New States Collaborate to Tackle Child Care Challenges Nationwide
  • Unlock Free Earnings with DRML Miner's New Cloud Platform
  • Tom Lee's Vision for Ethereum at BitMine Immersion Technologies
  • SoundHound AI Stock Surge: Understanding Recent Dynamics
  • Analyzing Short Interest Trends for Merck & Co (MRK)
  • Understanding the Surge in New Fortress Energy's Short Interest
  • Investors Reactions to UnitedHealth Group's Short Interest Trends
  • Investors Eye CorMedix's Promising Growth Potential Ahead
  • Vor Biopharma's Major Investment Targets Autoimmune Market Growth
  • Binaytara Expands Cancer Care and Research with Grant Support
  • Particle Dynamics Strengthens Global Operations with Key Acquisition
  • Iovance Biotherapeutics Securities Lawsuit: Key Insights for Investors
  • Future of the PMU Market: Expected Growth and Trends
  • Significant Growth in the European Single-use Bioreactors Sector
  • Investors of Red Cat Holdings, Inc. Invited to Join Lawsuit
  • Investors Gain Ground in West Pharmaceutical Class Action Case
  • Warm Edge Spacer Market Set for $1.9 Billion Growth by 2035
  • Inspiring Makeover: Lenny Kravitz Emerges as Top Dog Champion
  • Strategic Leadership in Florida to Enhance Behavioral Health
  • BASX Unveils Sustainable Cooling Solutions for AI Data Centers
  • Ress Life Investments A/S Reports Latest Net Asset Value Update
  • Kraken Robotics Inc. Completes Final Prospectus for Major Offering
  • Tevogen's CEO Invests in Building Stronger Future with New HQ
  • NVIDIA Stock Analysis: Recent Performances and Future Outlook
  • Transforming Toronto's Rental Landscape: A Strategic Partnership
  • Compass Diversified Holdings Faces Class Action Lawsuit Update
  • Kleinknecht Electric Transforms Operations with SIS CRM Solution
  • Key Ruling in Niger Delta Oil Pollution Issue by High Court
  • Empowering Health Decisions: jscreen's Summer Initiative
  • Exploring Growth in North America's LIMS Market into 2032
  • Unlock Outdoor Comfort with FlexPatio's Revolutionary System
  • How Major Companies Are Boosting Buybacks This Year
  • Kleinknecht Electric Companies Launches SIS CRM for Electrical Projects
  • Aardvark Therapeutics: Innovating Weight Loss Solutions
  • Understanding Amphenol's Stock Performance and Valuation Metrics
  • Insiders and Investors Weigh in on Credo Technology Group
  • IonQ's Options Activity Insights and Market Trends Unveiled
  • Discover the Visionary Works of Mara Sfara at Medici Museum
  • Analyzing the Recent Bullish Options Activity of Howmet Aerospace
  • Graybar Secures $750 Million Credit Facility for Growth
  • Consumers Energy Unveils Tool to Aid Customers in Saving Energy
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site